This company listing is no longer active
Cantargia Past Earnings Performance
Past criteria checks 0/6
Key information
-40.7%
Earnings growth rate
-11.3%
EPS growth rate
Biotechs Industry Growth | 0.7% |
Revenue growth rate | n/a |
Return on equity | -98.6% |
Net Margin | n/a |
Next Earnings Update | 30 Aug 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Cantargia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 22 | 0 | -411 | 16 | 400 |
31 Dec 21 | 0 | -367 | 15 | 353 |
30 Sep 21 | 0 | -319 | 16 | 304 |
30 Jun 21 | 0 | -255 | 16 | 239 |
31 Mar 21 | 0 | -206 | 15 | 191 |
31 Dec 20 | 0 | -173 | 15 | 158 |
30 Sep 20 | 0 | -153 | 15 | 138 |
30 Jun 20 | 0 | -139 | 14 | 126 |
31 Mar 20 | 0 | -127 | 14 | 113 |
31 Dec 19 | 0 | -111 | 13 | 97 |
30 Sep 19 | 0 | -102 | 12 | 90 |
30 Jun 19 | 0 | -98 | 14 | 83 |
31 Mar 19 | 0 | -101 | 16 | 85 |
31 Dec 18 | 0 | -91 | 16 | 77 |
30 Sep 18 | 0 | -78 | 10 | 104 |
30 Jun 18 | 0 | -68 | 9 | 87 |
31 Mar 18 | 0 | -56 | 7 | 65 |
31 Dec 17 | 0 | -60 | 7 | 52 |
30 Sep 17 | 0 | -65 | 14 | 0 |
30 Jun 17 | 0 | -66 | 13 | 0 |
31 Mar 17 | 0 | -58 | 12 | 0 |
31 Dec 16 | 0 | -47 | 12 | 0 |
30 Sep 16 | 0 | -34 | 12 | 0 |
30 Jun 16 | 0 | -24 | 11 | 0 |
31 Mar 16 | 0 | -22 | 11 | 0 |
31 Dec 15 | 0 | -17 | 10 | 0 |
Quality Earnings: CANTA BTA is currently unprofitable.
Growing Profit Margin: CANTA BTA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CANTA BTA is unprofitable, and losses have increased over the past 5 years at a rate of 40.7% per year.
Accelerating Growth: Unable to compare CANTA BTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CANTA BTA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15.1%).
Return on Equity
High ROE: CANTA BTA has a negative Return on Equity (-98.62%), as it is currently unprofitable.